Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 1/2 2Phase 1 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 34Pancreatic Neoplasms 19Colonic Neoplasms 10Rectal Neoplasms 8Stomach Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasms 6Neoplasm Metastasis 6Gastrointestinal Neoplasms 6Esophageal Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Biliary Tract Neoplasms 5Advanced Solid Tumors 4Triple Negative Breast Neoplasms 3Melanoma 3Endometrial Neoplasms 3Carcinoma, Squamous Cell 3Adenocarcinoma Of Esophagus 3Squamous Cell Carcinoma of Head and Neck 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Liver Neoplasms 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Transitional Cell 2Carcinoma, Hepatocellular 2Carcinoma 2Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC 1Solid Cancer 1Small Cell Lung Carcinoma 1Sarcoma 1

Interventions

pembrolizumab 21lenvatinib 8Paclitaxel 5patritumab deruxtecan 3enfortumab vedotin 2belzutifan 2Tretinoin 2Surgical Procedures, Operative 2Oxaliplatin 2Leucovorin 2Irinotecan 2Fluorouracil 2Carboplatin 2Capecitabine 2tremelimumab 1trametinib 1poly ICLC 1epacadostat 1efineptakin alfa 1durvalumab 1dabrafenib 1Ramucirumab 1Radiotherapy 1Radiosurgery 1Radiation 1Pemetrexed 1Levoleucovorin 1Immunotherapy 1Histamine H2 Antagonists 1Histamine Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Parkinson Disease 4, Autosomal Dominant Lewy Body × Leucovorin × Clear all
NCT06469944 2026-05-26

MK-3475-06C

Merck Sharp & Dohme LLC

Phase 1/2 Recruiting
160 enrolled
Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms

NCT02735239 2024-03-22

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Ludwig Institute for Cancer Research

Phase 1/2 Completed
73 enrolled 18 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡